Meeting
2016 ASCO Annual Meeting
Total mutation burden (TMB) in lung cancer (LC) and relationship with response to PD-1/PD-L1 targeted therapies.
Authors
David R. Spigel
Sarah Cannon Research Institute, Nashville, TN
David R. Spigel , Alexa Betzig Schrock , David Fabrizio , Garrett Michael Frampton , James Sun , Jie He , Kyle Gowen , Melissa Lynne Johnson , Todd Michael Bauer , Gregory Peter Kalemkerian , Luis E. Raez , Sai-Hong Ignatius Ou , Jeffrey S. Ross , Philip J. Stephens , Vincent A. Miller , Siraj Mahamed Ali
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 34, 2016 (suppl; abstr 9017)
DOI
10.1200/JCO.2016.34.15_suppl.9017
Abstract #
9017
Poster Bd #
340
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Mutational landscape of pancreatic adenocarcinoma identified by prospective clinical sequencing in a nationwide cancer network.
First Author: Katherine E Poruk
Poster
2022 ASCO Annual Meeting
Molecular characterization of NF1-mutated NSCLC and clinical outcomes.
First Author: Christopher Gates
Poster
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations.
First Author: Laurent Mhanna
Poster
2017 Gastrointestinal Cancers Symposium
Molecular characterization of squamous cell carcinoma of the anal canal (SCCA).
First Author: Benjamin Adam Weinberg